切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2025, Vol. 14 ›› Issue (01) : 57 -59. doi: 10.3877/cma.j.issn.2095-3216.2025.01.010

病例报告

常染色体显性遗传肾小管间质性肾病1 例并文献复习
包开花1,2, 王小龙1, 吴杰1,(), 陈仆1, 谢院生1, 蔡广研1   
  1. 1. 100853 北京,中国人民解放军总医院第一医学中心肾脏病医学部、肾脏疾病全国重点实验室、国家慢性肾病临床医学研究中心、肾脏疾病研究北京市重点实验室
    2. 46003021-9 内蒙古民族大学附属医院
  • 收稿日期:2023-12-01 出版日期:2025-02-28
  • 通信作者: 吴杰

Autosomal dominant tubulointerstitial kidney disease:a case report with literature review

Kaihua Bao, Xiaolong Wang, Jie Wu(), Pu Chen, Yuansheng Xie, Guangyan Cai   

  • Received:2023-12-01 Published:2025-02-28
  • Corresponding author: Jie Wu
引用本文:

包开花, 王小龙, 吴杰, 陈仆, 谢院生, 蔡广研. 常染色体显性遗传肾小管间质性肾病1 例并文献复习[J/OL]. 中华肾病研究电子杂志, 2025, 14(01): 57-59.

Kaihua Bao, Xiaolong Wang, Jie Wu, Pu Chen, Yuansheng Xie, Guangyan Cai. Autosomal dominant tubulointerstitial kidney disease:a case report with literature review[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2025, 14(01): 57-59.

图1 患者家系图
图2 患者及家庭成员基因检测结果 注:A:先证者UMOD 基因外显子3 的杂合突变(c.586A>C);B:长子UMOD 基因外显子3 的杂合突变(c.586A>C);C: 大侄女UMOD 基因外显子3 的杂合突变(c.586A>C);D: 弟弟UMOD 基因外显子3 的杂合突变(c.586A>C);E: 小侄女UMOD 基因外显子3 的杂合突变(c.586A>C);F: 次子UMOD 基因外显子3 的杂合突变(c.586A>C)
[1]
Hart TC, Gorry MC, Hart PS, et al.Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy [J].J Med Genet,2002, 39(12): 882-892.
[2]
石红光, 赵学智.尿调节素相关肾病[J].中华肾脏病杂志,2013, 29(7): 542-546.
[3]
Wei X, Xu R, Yang Z, et al.Novel uromodulin mutation in familial juvenile hyperuricemic nephropathy [J].Am J Nephrol,2012, 36(2): 114-120.
[4]
Kaminska-Pajak KA, Dyga K, Adamczyk P, et al.Familial juvenile hyperuricemic nephropathy as rare cause of dialysisdependent chronic kidney disease-a series of cases in two families[J].Ren Fail, 2016, 38(10): 1759-1762.
[5]
Salgueiro G, Beltran LM, Torres RJ, et al.Fenofibrate increases serum creatinine in a patient with familial nephropathy associated to hyperuricemia [J].Nucleosides Nucleotides Nucleic Acids,2014, 33(4-6): 181-184.
[6]
Bleyer AJ, Kidd K, Živná M, et al.Autosomal dominant tubulointerstitial kidney disease [J].Adv Chronic Kidney Dis,2017, 24(2): 86-93.
[7]
Duncan H, Dixon AS.Gout, familial hypericaemia, and renal disease [J].Q J Med, 1960, 29: 127-135.
[8]
Lhotta K, Piret SE, Kpamar R, et al.Epidemiology of uromodulin-associated kidney disease-results from a nation-wide survey [J].Nephron Extra, 2012, 2(1): 147-158.
[9]
Bleyer AJ, Hart PS, Kmoch S.Hereditary interstitial kidney disease [J].Semin Nephrol, 2010, 30(4): 366-373.
[10]
Bleyer AJ, Hart TC, Willingham MC, et al.Clinicopathologic findings in medullary cystic kidney disease type 2 [J].Pediatr Nephrol, 2005, 20(6): 824-827.
[11]
Pirson Y, Loutc G, Cosyns JP, et al.Autosomal-dominant chronic interstitial nephritis with early hyperuricemia [J].Adv Nephrol Necker Hosp, 2000, 30: 357-369.
[12]
Fairbanks LD, Cameron JS, Venkat-Raman G, et al.Early treatment with allopurinol in familial juvenile hyerpuricemic nephropathy (FJHN) ameliorates the long-term progression of renal disease [J].QJM, 2002, 95(9): 597-607.
[13]
Hamada T, Ichida K, Hosoyamada M, et al.Uricosuric action of losartan via the inhibition of urate transporter I (URAT 1) in hypertensive patients [J].Am J Hypertens, 2008, 21(10):1157-1162.
[14]
Kudo E, Kamatani N, Tezuka O, et al.Familial juvenile hyperuricemic nephropathy: detection of mutations in the uromodulin gene in five Japanese families [J].Kidney Int,2004, 65(5): 1589-1597.
[15]
Williams SE, Reed AAC, Galvanovskis J, et al.Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum [J].Hum Mol Genet, 2009, 18(16):2963-2974.
[16]
黄岩龙, 黄海长, 王文堂, 等.家族性青少年高尿酸血症肾病家系患者尿调节素编码基因突变位点研究[J/OL].中华肾病研究电子杂志, 2015, 4(2): 28-31.
No related articles found!
阅读次数
全文


摘要